NCT07694674 Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease Status RECRUITING Phase N/A
NCT07683975 Infliximab for Immune Checkpoint Inhibitor Associated AKI Status NOT_YET_RECRUITING Phase PHASE4
NCT07657312 Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma Status RECRUITING Phase PHASE2
NCT07619898 PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure Status NOT_YET_RECRUITING Phase PHASE2
NCT07550673 Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis(UPRISE) Status RECRUITING Phase PHASE4
NCT07491913 Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission Status RECRUITING Phase NA
NCT07417696 Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease Status NOT_YET_RECRUITING Phase PHASE4
NCT07415473 Akkermansia Muciniphila Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease Status NOT_YET_RECRUITING Phase PHASE4
NCT07352566 Utilization of a Microdevice for Psoriasis and Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE4
NCT07297069 Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial Status NOT_YET_RECRUITING Phase PHASE2
NCT07263477 A Study on the Relationship of Interleukin-7 Receptor Gene Polymorphisms With the Risk of Crohn's Disease Onset and the Efficacy of Infliximab Status COMPLETED Phase N/A
NCT07176754 TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest. Status ACTIVE_NOT_RECRUITING Phase NA
NCT07149441 Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study Status ACTIVE_NOT_RECRUITING Phase NA
NCT07138898 Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty Status RECRUITING Phase PHASE2
NCT06941376 An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis Status RECRUITING Phase PHASE2
NCT06786507 A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis Status NOT_YET_RECRUITING Phase N/A
NCT06758024 PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease Status RECRUITING Phase NA
NCT06646016 EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis Status WITHDRAWN Phase PHASE2
NCT06614387 Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab Status NOT_YET_RECRUITING Phase PHASE3
NCT06453317 Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis Status RECRUITING Phase PHASE2